# The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

> **NCT02184442** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 560 (actual)

## Conditions studied

- Severe
- Symptomatic
- Calcific Aortic Stenosis

## Interventions

- **DEVICE:** TAVR Implantation with SAPIEN XT
- **DEVICE:** TAVR Implantation with SAPIEN

## Key facts

- **NCT ID:** NCT02184442
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-09
- **Primary completion:** 2013-05-01
- **Final completion:** 2017-05-30
- **Target enrollment:** 560 (ACTUAL)
- **Last updated:** 2018-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02184442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02184442, "The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02184442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*